Journal
NANOMATERIALS
Volume 11, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/nano11051272
Keywords
folic acid; folate receptor; folate targeted; electrochemical sensor; cancer biomarker; rGO-FA; differential pulse voltammetry; biosensor
Categories
Funding
- Ministry of Higher Education (MOHE), Malaysia [FRGS/1/2016/STG07/UNIM/02/1]
- Tallinn University ASTRA project TU TEE-Tallinn University as a promoter of intelligent lifestyle - European Union European Regional Development Fund [2014-2020.4.01.16-0033]
Ask authors/readers for more resources
The study developed an electrochemical sensor for cancer detection using rGO-FA nanosheets targeting folate receptors (FRs) to control the disease and provide earlier treatments. The sensor exhibited excellent electrochemical performance towards FRs detection and offers great promise in the future medical industry.
The detection of cancer biomarkers in the early stages could prevent cancer-related deaths significantly. Nanomaterials combined with biomolecules are extensively used in drug delivery, imaging, and sensing applications by targeting the overexpressed cancer proteins such as folate receptors (FRs) to control the disease by providing earlier treatments. In this investigation, biocompatible reduced graphene oxide (rGO) nanosheets combined with folic acid (FA)-a vitamin with high bioaffinity to FRs-is utilized to develop an electrochemical sensor for cancer detection. To mimic the cancer cell environment, FR-beta protein is used to evaluate the response of the rGO-FA sensor. The formation of the rGO-FA nanocomposite was confirmed through various characterization techniques. A glassy carbon (GC) electrode was then modified with the obtained rGO-FA and analyzed via differential pulse voltammetry (DPV) for its specific detection towards FRs. Using the DPV technique, the rGO-FA-modified electrode exhibited a limit of detection (LOD) of 1.69 pM, determined in a linear concentration range from 6 to 100 pM. This excellent electrochemical performance towards FRs detection could provide a significant contribution towards future cancer diagnosis. Moreover, the rGO-FA sensing platform also showed excellent specificity and reliability when tested against similar interfering biomolecules. This rGO-FA sensor offers a great promise to the future medical industry through its highly sensitive detection towards FRs in a fast, reliable, and economical way.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available